GERN FY 2009 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-38.4% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$70M-4069.2% margin

Net Income

-$70M-4066.3% margin

EPS (Diluted)

$-0.80

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$45M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$180M

Total Liabilities

$8M

Stockholders' Equity

$173M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-38.4%
Gross Profit	$2M	$3M	-38.4%
Operating Income	-$70M	-$67M	-4.8%
Net Income	-$70M	-$62M	-13.2%